Teresa Barata

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain

Laia Domingo, Dolores Salas, Raquel Zubizarreta et al. · Breast Cancer Research · 2014 · 80 citations · Full text

Medicine, Oncology, Radiology +16

Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield et al. · Thyroid · 2023 · 55 citations · Full text

Medicine, Oncology, Pharmacology +13

Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program

Marisa Baré, Núria Torà, Dolores Salas et al. · Breast Cancer Research and Treatment · 2015 · 49 citations

Medicine, Oncology, Radiology +17

Structure−Activity Relationships of Monomeric C2-Aryl Pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine (PBD) Antitumor Agents

Dyeison Antonow, Maciej Kaliszczak, Gyoung‐Dong Kang et al. · Journal of Medicinal Chemistry · 2010 · 42 citations

Medicine, Medicinal Chemistry, Pharmacology +17